Format
Sort by
Items per page

Send to

Choose Destination

Best matches for bacteremia AND enterococcus AND malignant neoplasms AND vancomycin:

Search results

Items: 1 to 20 of 74

1.

Vancomycin-resistant Enterococcus bacteremia in a child with acute myeloid leukemia: successful treatment with daptomycin.

Büyükcam A, Karadağ Öncel E, Özsürekçi Y, Cengiz AB, Kuşkonmaz B, Sancak B.

Arch Argent Pediatr. 2016 Dec 1;114(6):e432-e435. doi: 10.5546/aap.2016.eng.e432. English, Spanish.

2.

Daptomycin non-susceptible Enterococcus faecium in leukemia patients: Role of prior daptomycin exposure.

DiPippo AJ, Tverdek FP, Tarrand JJ, Munita JM, Tran TT, Arias CA, Shelburne SA, Aitken SL.

J Infect. 2017 Mar;74(3):243-247. doi: 10.1016/j.jinf.2016.11.004. Epub 2016 Nov 11.

PMID:
27845153
3.

Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.

Chong PP, van Duin D, Bangdiwala A, Ivanova A, Miller WC, Weber DJ, Gilligan PH, Shea TC.

Clin Ther. 2016 Nov;38(11):2468-2476. doi: 10.1016/j.clinthera.2016.09.011. Epub 2016 Oct 19.

PMID:
27771176
4.

Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.

Hefazi M, Damlaj M, Alkhateeb HB, Partain DK, Patel R, Razonable RR, Gastineau DA, Al-Kali A, Hashmi SK, Hogan WJ, Litzow MR, Patnaik MM.

Transpl Infect Dis. 2016 Dec;18(6):913-920. doi: 10.1111/tid.12612. Epub 2016 Nov 11.

PMID:
27642723
6.

Emergence of vancomycin-resistant Enterococcus at a tertiary paediatric hospital in South Africa.

Lochan H, Moodley C, Rip D, Bamford C, Hendricks M, Davidson A, Eley B.

S Afr Med J. 2016 May 9;106(6):39-43. doi: 10.7196/SAMJ.2016.v106i6.10858.

PMID:
27245716
7.
8.

Discontinuation of Systematic Surveillance and Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) and Its Impact on the Incidence of VRE faecium Bacteremia in Patients with Hematologic Malignancies.

Almyroudis NG, Osawa R, Samonis G, Wetzler M, Wang ES, McCarthy PL, Segal BH.

Infect Control Hosp Epidemiol. 2016 Apr;37(4):398-403. doi: 10.1017/ice.2015.310. Epub 2016 Jan 11.

PMID:
26750087
9.

Role of intestinal microbiota in transplantation outcomes.

Taur Y, Jenq RR, Ubeda C, van den Brink M, Pamer EG.

Best Pract Res Clin Haematol. 2015 Jun-Sep;28(2-3):155-61. doi: 10.1016/j.beha.2015.10.013. Epub 2015 Oct 22. Review.

10.

Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer.

Chaftari AM, Hachem R, Jordan M, Garoge K, Al Hamal Z, El Zakhem A, Viola GM, Granwehr B, Mulanovich V, Gagel A, Reitzel R, Yousif A, Jiang Y, Raad I.

Antimicrob Agents Chemother. 2015 Oct 19;60(1):239-44. doi: 10.1128/AAC.00617-15.

11.

Vancomycin-resistant enterococci colonization in patients with hematological malignancies: screening and its cost-effectiveness.

Gedik H, Şimşek F, Kantürk A, Yıldırmak T, Arıca D, Aydın D, Yokuş O, Demirel N.

Afr Health Sci. 2014 Dec;14(4):899-905. doi: 10.4314/ahs.v14i4.18.

12.

Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukemia: different patterns in patients with acute myelogenous and acute lymphoblastic leukemia.

Ford CD, Lopansri BK, Haydoura S, Snow G, Dascomb KK, Asch J, Bo Petersen F, Burke JP.

Infect Control Hosp Epidemiol. 2015 Jan;36(1):47-53. doi: 10.1017/ice.2014.3.

PMID:
25627761
13.

Impact of vancomycin-resistant enterococcal bacteremia on outcome during acute myeloid leukemia induction therapy.

Ornstein MC, Mukherjee S, Keng M, Elson P, Tiu RV, Saunthararajah Y, Maggiotto A, Schaub M, Banks D, Advani A, Kalaycio M, Maciejewski JP, Sekeres MA.

Leuk Lymphoma. 2015;56(9):2536-42. doi: 10.3109/10428194.2014.1003557. Epub 2015 Feb 20.

PMID:
25563427
14.

Assessing outcomes of adult oncology patients treated with linezolid versus daptomycin for bacteremia due to vancomycin-resistant Enterococcus.

Patel K, Kabir R, Ahmad S, Allen SL.

J Oncol Pharm Pract. 2016 Apr;22(2):212-8. doi: 10.1177/1078155214556523. Epub 2014 Oct 17.

PMID:
25326010
15.

Frequency of bacterial isolates and pattern of antimicrobial resistance in patients with hematological malignancies: A snapshot from tertiary cancer center.

Sengar M, Kelkar R, Jain H, Biswas S, Pawaskar P, Karpe A.

Indian J Cancer. 2014 Oct-Dec;51(4):456-8. doi: 10.4103/0019-509X.175387.

16.

Microbiology, infection control and infection related outcome in pediatric patients in an oncology center in Eastern India: Experience from Tata Medical Center, Kolkata.

Bhattacharyya A, Krishnan S, Saha V, Goel G, Bhattacharya S, Hmar L.

Indian J Cancer. 2014 Oct-Dec;51(4):415-7. doi: 10.4103/0019-509X.175365.

17.

Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies.

Gedik H, Yıldırmak T, Simşek F, Kantürk A, Arıca D, Aydın D, Yokuş O, Demirel N, Arabacı C.

J Infect Dev Ctries. 2014 Sep 12;8(9):1113-8. doi: 10.3855/jidc.4451.

18.

Vancomycin resistant enterococcus bacteremia in a patient with Pneumocystis jiroveci pneumonia, granulocystic sarcoma and acute respiratory distress syndrome.

Emre JC, Baysak A, Oz AT, Ece G, Arda B, Bacakoglu F.

Pan Afr Med J. 2014 Jan 23;17:49. doi: 10.11604/pamj.2014.17.49.3246. eCollection 2014.

19.

The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients.

Satlin MJ, Soave R, Racanelli AC, Shore TB, van Besien K, Jenkins SG, Walsh TJ.

Leuk Lymphoma. 2014 Dec;55(12):2858-65. doi: 10.3109/10428194.2014.896007. Epub 2014 Mar 24.

20.

The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies.

Gedik H, Yildirmak T, Simsek F, Kanturk A, Aydýn D, Anca D, Yokus O, Demirel N.

Afr Health Sci. 2013 Jun;13(2):362-8. doi: 10.4314/ahs.v13i2.24.

Supplemental Content

Loading ...
Support Center